Jump to content

Draft:Mathematical oncology

From Wikipedia, the free encyclopedia
(Redirected from User:Isaac Jung/sandbox)
  • Comment: This draft seems to be largely written with a large language model, which is generally not helpful for creating Wikipedia article content. Please rewrite this in your own words. Let me know if you have any questions! (please Reply to icon mention me on reply; thanks!) —TechnoSquirrel69 (sigh) 01:37, 22 September 2024 (UTC)

Mathematical Oncology is a specialized branch of oncology.:[1] in which mathematical methods, including modeling[2] and simulations,[3] are applied to the study of cancer[4] growth, progression, and treatment.[5] Researchers develop models that describe tumor dynamics, treatment responses, and potential outcomes, supporting the development of more effective treatment strategies.[6] Simulation of cancer behavior potentially reduces the need for early-phase experimental trials[7],.[8]

History of Mathematical Oncology

[edit]

The field has its roots in biological modeling.[9] The first mathematical model in oncology is often attributed to Armitage & Doll's 1954 multi-stage theory of cancer.[10] Based on a model of the age distribution of cancer, they theorized that an individual's cancer risk increases with a power of their age.[11] Interest in mathematical models of cancer grew in the 1970s. Greenspan[12] developed a model for the growth of solid tumors.[13]

Wheldon[14] introduced a linear-quadratic model for cell death under radiotherapy to calibrate treatment protocols.[15] Balding & McElwain proposed the first mathematical models of angiogenesis[16] of tumors in 1985[17] To address the heterogeneity[18] of tumor cells, mathematical oncology shifted to stochastic[19] models in the 1990s to account for variability in cancer cell behavior.[20] By the early 2000s, ARA Anderson and colleagues had developed multi-scale hybrid models,[21] combining continuous and discrete variables[22] to study cell response to external chemical stimuli[23] and influence of cellular interaction on tumor structure[24] Ludwig von Bertalanffy[25] developed a model for organism growth that linked metabolic processes to surface area that became foundational to understanding tumor growth dynamics[26] Benjamin Gompertz[27] introduced the "law of population growth," which was adapted by cancer researchers into what is now known as the Gompertzian growth model.[28] This model describes how tumors initially grow rapidly, then growth slows as they reach a limiting size.[29] The Norton-Simon hypothesis[30] proposed by Richard Simon[31] and Larry Norton,[32] suggested that a tumor's response to chemotherapy is inversely proportional to its size. This hypothesis led to the development of "dose-dense" chemotherapy,[33] focusing on removing as much of the tumor mass as early as possible to maximize treatment efficacy. The hypothesis states that 1) chemotherapy efficacy decreases as tumor size increases, and 2) tumor growth rates slow as tumors enlarge, with dose-dense treatments aiming to prevent tumor regrowth between cycles of chemotherapy.[34] With progress made in the field of mathematical oncology over the past decades, there is growing collaboration among cancer researchers and mathematical modelers to better understand cancer and improve treatment options.[35]

Core Concepts and Methods

[edit]

Mathematical Modeling: Mathematical oncology employs both deterministic[36] and stochastic[37] models to simulate tumor behavior. These models frequently rely on ordinary differential equations (ODEs)[38] and partial differential equations (PDEs)[39] to represent tumor growth, angiogenesis,[40] metastasis development,[41] and treatment responses. For instance, ODEs might be used to describe tumor cell proliferation[42] over time, while PDEs capture more complex systems involving spatial and temporal dynamics[43],[44] Optimization and Control Theory: Control theory[45] and optimization[46] are applied to treatment planning in cancer therapies, particularly in radiotherapy[47] and chemotherapy.[48] By optimizing dose schedules and timing, mathematical oncology aims to maximize therapeutic efficacy while minimizing adverse effects.[49] Statistical Methods and AI: Statistical methods[50] are crucial for understanding cancer progression, analyzing treatment outcomes, and identifying significant trends in large data sets.[51] Recent advances in artificial intelligence (AI)[52] and machine learning[53] have further revolutionized the field. AI algorithms[54] can process vast amounts of patient data and identify patterns that may predict individual responses to treatment, personalizing therapeutic strategies.[55] Computational Techniques: Recent advancements in computational techniques, particularly in AI, have significantly accelerated progress in mathematical oncology.[56] AI allows researchers to predict the behavior of individual cells with greater accuracy by integrating diverse types of patient data. AI-driven models can also identify mathematical equations that more precisely reflect tumor growth dynamics, helping researchers uncover relationships between various biological factors more quickly.[57] This integration of computational power and AI may enhance the ability to guide treatment decisions and optimize cancer therapies.[58]

Applications in Cancer Research and Treatment

[edit]

Mathematical models provide insight into key aspects of cancer biology: Tumor Growth and Progression: Models like the Gompertzian model[59] describe how tumors grow and evolve over time. These models can also predict how tumors invade surrounding tissues or metastasize to other organs.[60] Treatment Response: Mathematical oncology has played a significant role in predicting how patients will respond to chemotherapy, radiotherapy, and immunotherapy.[61] By modeling cancer cell dynamics under treatment, oncologists[62] can better plan personalized therapies[63],.[64] Personalized Medicine: Mathematical models may help to determine the optimal treatment schedules for cancer.[65] Clinical Trials: Mathematical models may be used to run virtual (in silico) clinical trials[66] with the goal of predicting the heterogeneous effects of drugs on patient populations.[67]

Interdisciplinary Collaborations

[edit]

Mathematical oncology is an interdisciplinary field that draws from biology,[68] mathematics,[69] physics,[70] and computer science.[71] Many advancements in mathematical oncology are made through collaboration with other fields such as bioinformatics,[72] systems biology,[73] medical physics,[74] medical imaging[75] and radiation therapy. [76][77][78]

Recent Advances and Current Research

[edit]

Recent developments in AI and machine learning have allowed for accelerated development of mathematical models of cancer behavior, using genome sequencing and large data. For instance, algorithms that integrate patient genetic data with clinical data can generate highly personalized treatment protocols. Researchers are also investigating how multiscale modeling[79] (linking molecular, cellular, and tissue-level data) can offer more holistic insights into cancer dynamics.[80] Significant studies have focused on modeling the immune system[81] interactions with tumors and the role of tumor heterogeneity[82] in treatment resistance.[83] Current projects aim to refine these models, making them more robust and clinically relevant[84]

Challenges and Future Directions

[edit]

Despite significant progress, the complexity of cancer biology presents ongoing challenges for mathematical modeling. Accurately simulating the interactions of thousands of biological variables requires high-quality data, which is often difficult to obtain. Only a small percentage of mathematically-driven treatments advance through clinical trials, highlighting the difficulty in translating models into clinical practice.[85] Researchers are now focusing on improving the quality of data used in these models and finding ways to apply them more effectively in early-stage clinical trials. Integrating models with genomic data[86] and expanding their role in personalized oncology are key areas of future development. However, poor-quality data continues to compromise predictions, making it difficult to identify significant relationships between variables. This can lead to models that are ineffective or underutilized in clinical practice.[87] Addressing data quality and improving model precision remain significant challenges in the field.[88]

Institutions and Researchers

[edit]

Mathematical oncology is advanced by a network of leading institutions worldwide. Some of the most prominent include: Moffitt Cancer Center's Integrated Mathematical Oncology Program (Tampa, FL)[89] Center for Computational Oncology (Austin, TX)[90] City of Hope's Division of Mathematical Oncology (Duarte, CA)[91] Researchers in the field, such as Dr. Russell Rockne,[92] Dr. Alexander "Sandy" Anderson,[93] and other leaders[94] have made significant contributions to mathematical oncology, developing models and driving clinical applications. Leading Research Centers include[95] Adler Lab – Salt Lake City, UT Cancitis Research Group – Roskilde, Denmark Center for Computational Oncology – Austin, TX Mathematical Oncology and Computational System Biology – Duarte, CA Department of Evolutionary Theory – Plön, Germany Fertig Lab – Baltimore, MD George Research Group – Houston, TX Hillen Research Group – Edmonton, Canada Immune Biology of MSI Cancer – Heidelberg, Germany In Silico Modeling Group – Nicosia, Cyprus Innovative Methods of Computing – Dresden, Germany Janes Lab – Charlottesville, VA Jenner Lab – Brisbane, Australia MacLean Lab – Los Angeles, CA MOLAB – Ciudad Real, Spain Multiscale Modeling of Multicellular Systems – Abu Dhabi, UAE Noble Group – London, UK Quantitative and Translational Medicine Laboratory – Montreal, Canada Quantitative Cancer Control Lab – San Diego, CA Quantitative Personalized Oncology Lab – Tampa, FL Theory Division – Cleveland, OH These centers and researchers are at the forefront of integrating mathematics with cancer biology to improve cancer treatment strategies and deepen our understanding of tumor behavior.

Impact on Cancer Treatment

[edit]

Mathematical oncology has already influenced treatment protocols[96] in areas such as radiotherapy[97] and chemotherapy.[98]

Case studies[99] show how modeling tumor dynamics can lead to more effective dose schedules, improving patient outcomes and minimizing side effects.[100] Models have also informed the development of adaptive therapies, which adjust treatment based on the evolving characteristics of the tumor[101]

Educational Resources and Training

[edit]

Numerous academic programs and workshops are dedicated to advancing the field of mathematical oncology, with many of these hosted by leading universities and international conferences. These programs aim to equip the next generation of researchers with the mathematical and computational tools required for oncology research. Many academic institutions offer specialized courses in mathematical oncology, often integrated within broader fields such as computational biology or applied mathematics. Conferences held by the Society for Mathematical Biology,[102] the European Society for Mathematical and Theoretical Biology,[103] the International Society for Computational Biology[104] provide ongoing education and networking opportunities for professionals in the field. These platforms serve as critical venues for collaboration, offering insights into the latest computational techniques and the translation of mathematical models into clinical practice.

References

[edit]
  1. ^ "Oncology".
  2. ^ "Mathematical model".
  3. ^ "Simulation".
  4. ^ "Cancer".
  5. ^ Altrock, P., Liu, L. & Michor, F. The mathematics of cancer: integrating quantitative models. Nat Rev Cancer 15, 730–745 (2015). https://doi.org/10.1038/nrc4029
  6. ^ Gibin G. Powathil, Maciej Swat, Mark A.J. Chaplain, Systems oncology: Towards patient-specific treatment regimes informed by multiscale mathematical modeling, Seminars in Cancer Biology, Volume 30, 2015, Pages 13-20, ISSN 1044-579X, https://doi.org/10.1016/j.semcancer.2014.02.003.
  7. ^ "Phases of clinical research".
  8. ^ Chambers RB. The role of mathematical modeling in medical research: "research without patients?". Ochsner J. 2000 Oct;2(4):218-23. PMID: 21765699; PMCID: PMC3117507
  9. ^ Anderson, A., Quaranta, V. Integrative mathematical oncology. Nat Rev Cancer 8, 227–234 (2008). https://doi.org/10.1038/nrc2329
  10. ^ https://en.wikipedia.org/wiki/Armitage%E2%80%93Doll_multistage_model_of_carcinogenesis
  11. ^ Armitage, P., Doll, R. The Age Distribution of Cancer and a Multi-stage Theory of Carcinogenesis. Br J Cancer 8, 1–12 (1954) https://doi.org/10.1038/bjc.1954.1
  12. ^ "Harvey P. Greenspan".
  13. ^ H.P. Greenspan, On the growth and stability of cell cultures and solid tumors, Journal of Theoretical Biology, Volume 56, Issue 1, 1976, Pages 229-242, ISSN 0022-5193,https://doi.org/10.1016/S0022-5193(76)80054-9
  14. ^ Halnan, Keith (7 July 2000). "Tom Wheldon". The Guardian.
  15. ^ T. E. Wheldon, J. Kirk, J. S. Orr, Optimal radiotherapy of tumor cells following exponential-quadratic survival curves and exponential repopulation kinetics, British Journal of Radiology, Volume 50, Issue 597, 1 September 1977, Pages 681–682, https://doi.org/10.1259/0007-1285-50-597-681
  16. ^ "Angiogenesis".
  17. ^ Balding D, McElwain DL. A mathematical model of tumor-induced capillary growth. J Theor Biol. 1985 May 7;114(1):53-73. doi: 10.1016/s0022-5193(85)80255-1. PMID: 2409405.
  18. ^ "Homogeneity and heterogeneity".
  19. ^ "Stochastic simulation".
  20. ^ Suresh H. Moolgavkar, 12 Stochastic models of carcinogenesis,Handbook of Statistics, Elsevier, Volume 8,1991,Pages 373-393, ISSN 0169-7161,ISBN 9780444880956,https://doi.org/10.1016/S0169-7161(05)80168-3
  21. ^ McCartney, L. N. (2005). Multi-scale predictive modelling of cracking in laminate composites. In C. Soutis & P. W. R. Beaumont (Eds.), Multi-scale modelling of composite material systems (pp. 65–98). Woodhead Publishing. https://doi.org/10.1533/9781845690847.65
  22. ^ "Continuous or discrete variable".
  23. ^ Anderson AR, Chaplain MA. Continuous and discrete mathematical models of tumor-induced angiogenesis. Bull Math Biol. 1998 Sep;60(5):857-99. doi: 10.1006/bulm.1998.0042. PMID: 9739618
  24. ^ A. R. A. Anderson, "A hybrid mathematical model of solid tumor invasion: the importance of cell adhesion," in Mathematical Medicine and Biology: A Journal of the IMA, vol. 22, no. 2, pp. 163-186, June 2005, doi: 10.1093/imammb/dqi005.
  25. ^ "Ludwig von Bertalanffy".
  26. ^ Eikenberry, S. E. (2016). Introduction to Mathematical Oncology. Taylor & Francis Inc.
  27. ^ "Benjamin Gompertz".
  28. ^ "Gompertz function".
  29. ^ Eikenberry, S. E. (2016). Introduction to Mathematical Oncology. Taylor & Francis Inc.
  30. ^ Simon, Richard; Norton, Larry (2006). "The Norton–Simon hypothesis: Designing more effective and less toxic chemotherapeutic regimens". Nature Clinical Practice Oncology. 3 (8): 406–407. doi:10.1038/ncponc0560. PMID 16894366.
  31. ^ "Biometric Research Program (BRP)".
  32. ^ "Larry Norton, MD".
  33. ^ "Dose-dense chemotherapy".
  34. ^ Eikenberry, S. E. (2016). Introduction to Mathematical Oncology. Taylor & Francis Inc.
  35. ^ Byrne HM. Dissecting cancer through mathematics: from the cell to the animal model. Nat Rev Cancer. 2010 Mar;10(3):221-30. doi: 10.1038/nrc2808. PMID: 20179714
  36. ^ "Deterministic system".
  37. ^ "Stochastic process".
  38. ^ "Ordinary differential equation".
  39. ^ "Partial differential equation".
  40. ^ "Angiogenesis".
  41. ^ "Metastasis".
  42. ^ "Cell proliferation".
  43. ^ ODEs: Classification of differential equations.
  44. ^ McDonald, T.O., Cheng, YC., Graser, C. et al. Computational approaches to modeling and optimizing cancer treatment. Nat Rev Bioeng 1, 695–711 (2023). https://doi.org/10.1038/s44222-023-00089-7
  45. ^ "Control theory".
  46. ^ https://en.wikipedia.org/wiki/Mathematical_optimiza,tion
  47. ^ "Radiation therapy".
  48. ^ https://en.wikipedia.org/wiki/Chemotherap
  49. ^ Optimizing the future: how mathematical models inform treatment schedules for cancer Mathur, Deepti et al. Trends in Cancer, Volume 8, Issue 6, 506 - 516
  50. ^ "Statistical Methods in Medical Research".
  51. ^ "Data set".
  52. ^ "Artificial intelligence".
  53. ^ "Machine learning".
  54. ^ "Artificial intelligence in healthcare".
  55. ^ Janina Hesse, Nina Nelson, Angela Relógio, Shaping the future of precision oncology: Integrating circadian medicine and mathematical models for personalized cancer treatment, Current Opinion in Systems Biology, Volume 37,2024,100506,ISSN 2452-3100, https://doi.org/10.1016/j.coisb.2024.100506
  56. ^ Shimizu H, Nakayama KI. Artificial intelligence in oncology. Cancer Sci. 2020; 111: 1452–1460. https://doi.org/10.1111/cas.14377
  57. ^ El Naqa, I., Karolak, A., Luo, Y. et al. Translation of AI into oncology clinical practice. Oncogene 42, 3089–3097 (2023). https://doi.org/10.1038/s41388-023-02826-z
  58. ^ "AI and Cancer - NCI". 30 May 2024.
  59. ^ "Gompertz function".
  60. ^ Bernard, A., Kimko, H., Mital, D., & Poggesi, I. (2012). Mathematical modeling of tumor growth and tumor growth inhibition in oncology drug development. Expert Opinion on Drug Metabolism & Toxicology, 8(9), 1057–1069. https://doi.org/10.1517/17425255.2012.693480
  61. ^ "Immunotherapy".
  62. ^ "Oncology".
  63. ^ "Personalized medicine".
  64. ^ Hamis S, Powathil GG, Chaplain MAJ. Blackboard to Bedside: A Mathematical Modeling Bottom-Up Approach Toward Personalized Cancer Treatments. JCO Clin Cancer Inform. 2019 Feb;3:1-11. doi: 10.1200/CCI.18.00068. PMID: 30742485.
  65. ^ Mathur D, Barnett E, Scher HI, Xavier JB. Optimizing the future: how mathematical models inform treatment schedules for cancer Trends Cancer. 2022 Jun; 8(6): 506–516
  66. ^ "In silico clinical trials".
  67. ^ Craig M, Gevertz JL, Kareva I and Wilkie KP (2023), A practical guide for the generation of model-based virtual clinical trials. Front. Syst. Biol. 3:1174647. doi: 10.3389/fsysb.2023.1174647
  68. ^ "Biology".
  69. ^ "Mathematics".
  70. ^ "Physics".
  71. ^ "Computer science".
  72. ^ "Bioinformatics".
  73. ^ "Systems biology".
  74. ^ "Medical physics".
  75. ^ "Medical imaging".
  76. ^ Integrated mathematical oncology. Moffitt. (n.d.)
  77. ^ "Integrated Mathematical Oncology".
  78. ^ Carlos A. Valentim, José A. Rabi, Sergio A. David, Fractional Mathematical Oncology: On the potential of non-integer order calculus applied to interdisciplinary models, Biosystems,Volume 204,2021,104377,ISSN 0303-2647, https://doi.org/10.1016/j.biosystems.2021.104377.
  79. ^ "Multiscale modeling".
  80. ^ Byrne, H. Dissecting cancer through mathematics: from the cell to the animal model. Nat Rev Cancer 10, 221–230 (2010). https://doi.org/10.1038/nrc2808
  81. ^ "Immune system".
  82. ^ "Tumour heterogeneity".
  83. ^ Classical mathematical models for prediction of response to chemotherapy and immunotherapy. Ghaffari Laleh N, Loeffler CML, Grajek J, Staňková K, Pearson AT, et al. (2022) Classical mathematical models for prediction of response to chemotherapy and immunotherapy. PLOS Computational Biology 18(2): e1009822. https://doi.org/10.1371/journal.pcbi.1009822
  84. ^ Engineering in Medicine To Address the Challenge of Cancer Drug Resistance: From Micro- and Nanotechnologies to Computational and Mathematical Modeling Morgan Craig, Adrianne L. Jenner, Bumseok Namgung, Luke P. Lee, and Aaron Goldman. Chemical Reviews 2021 121 (6), 3352-3389 DOI: 10.1021/acs.chemrev.0c00356
  85. ^ New study shows the rate of drug approvals lower than previously reported. BIO. (n.d.). https://archive.bio.org/media/press-release/new-study-shows-rate-drug-approvals-lower-previously-reported#:~:text=Overall%20success%20rates%20from%20Phase,rate%20of%20one%20in%2030
  86. ^ "Computational genomics".
  87. ^ Markowetz, F. (2024, February 28). All models are wrong and yours are useless: Making clinical prediction models impactful for patients. Nature News.
  88. ^ Sancho-Araiz, Aymara, Victor Mangas-Sanjuan, and Iñaki F. Trocóniz. 2021. "The Role of Mathematical Models in Immuno-Oncology: Challenges and Future Perspectives" Pharmaceutics 13, no. 7: 1016. https://doi.org/10.3390/pharmaceutics13071016
  89. ^ "Integrated Mathematical Oncology".
  90. ^ https://cco.oden.utexas.edu/
  91. ^ https://www.cityofhope.org/research/beckman-research-institute/computational-and-quantitative-medicine/mathematical-oncology
  92. ^ https://www.cityofhope.org/russell-rockne
  93. ^ "Dr. Alexander Anderson's Story".
  94. ^ "Group Leaders". The Mathematical Oncology Blog.
  95. ^ -Oncology, M. (n.d.). Mathematical oncology. The Mathematical Oncology Blog. https://mathematical-oncology.org/
  96. ^ "Protocol".
  97. ^ Ghaderi, Nima, Joseph Jung, Sarah C. Brüningk, Ajay Subramanian, Lauren Nassour, and Jeffrey Peacock. 2022. "A Century of Fractionated Radiotherapy: How Mathematical Oncology Can Break the Rules" International Journal of Molecular Sciences 23, no. 3: 1316. https://doi.org/10.3390/ijms23031316
  98. ^ Ghaffari Laleh N, Loeffler CML, Grajek J, Staňková K, Pearson AT, et al. (2022) Classical mathematical models for prediction of response to chemotherapy and immunotherapy. PLOS Computational Biology 18(2): e1009822. https://doi.org/10.1371/journal.pcbi.1009822
  99. ^ "Case study".
  100. ^ Mathur D, Barnett E, Scher HI, Xavier JB. Optimizing the future: how mathematical models inform treatment schedules for cancer. Trends in Cancer. 2022 Jun;8(6):506-516. doi: 10.1016/j.trecan.2022.02.005. Epub 2022 Mar 9. PMID: 35277375; PMCID: PMC9117454.
  101. ^ 1.Derbal Y. Adaptive Cancer Therapy in the Age of Generative Artificial Intelligence. Cancer Control. 2024;31. doi:10.1177/10732748241264704
  102. ^ "Society for Mathematical Biology - Annual SMB Meetings".
  103. ^ https://www.esmtb.org/
  104. ^ "ISCB - International Society for Computational Biology".

Rockne RC, Scott JG. Introduction to Mathematical Oncology. JCO Clin Cancer Inform. 2019 Apr;3:1-4. doi: 10.1200/CCI.19.00010. PMID: 31026176; PMCID: PMC6752950. New study shows the rate of drug approvals lower than previously reported. BIO. (n.d.). https://archive.bio.org/media/press-release/new-study-shows-rate-drug-approvals-lower-previously-reported. Integrated mathematical oncology. Moffitt. (n.d.). https://www.moffitt.org/research-science/divisions-and-departments/quantitative-science/integrated-mathematical-oncology/ Oncology, M. (n.d.). Mathematical oncology. The Mathematical Oncology Blog. https://mathematical-oncology.org/ Markowetz, F. (2024, February 28). All models are wrong and yours are useless: Making clinical prediction models impactful for patients. Nature News. Eikenberry, S. E. (2016). Introduction to Mathematical Oncology. Taylor & Francis Inc. Adapted for Math 204 at the University of Victoria. (n.d.). Introduction to differential equations. ODEs: Classification of differential equations.[1](https://web.uvic.ca/~tbazett/diffyqs/classification_section.html#:~:text=Ordinary%20differential%20equations%20or%20(ODE,is%20only%20one%20independent%20variable.&text=Partial%20differential%20equations%20or%20(PDE,partial%20derivatives%20of%20several%20variables) AI and cancer. AI and Cancer - NCI. (n.d.). https://www.cancer.gov/research/infrastructure/artificial-intelligence

See also

[edit]

Cancer Systems Biology [2]

Bioinformatics [3]

Computational Biology [4]

Gompertz Function [5]

Ordinary Differential Equation [6]

Partial Differential Equation [7]

Oncology [8]

[edit]

Moffitt Cancer Center's Integrated Mathematical Oncology Program: https://www.moffitt.org/research-science/divisions-and-departments/quantitative-science/integrated-mathematical-oncology/ City of Hope's Division of Mathematical Oncology: https://www.cityofhope.org/research/mathematical-oncology Society for Mathematical Biology: https://www.smb.org/ Mathematical Oncology Blog: https://mathematical-oncology.org/ High School Mathematical Oncology https://hsmath-oncology.org

  1. ^ ODEs: Classification of differential equations.
  2. ^ "Cancer systems biology".
  3. ^ "Bioinformatics".
  4. ^ "Computational biology".
  5. ^ "Gompertz function".
  6. ^ "Ordinary differential equation".
  7. ^ "Partial differential equation".
  8. ^ "Oncology".
Retrieved from "https://en.wikipedia.org/w/index.php?title=Draft:Mathematical_oncology&oldid=1249139928"